[Premature ovarian failure]

Area of Science:

• Reproductive Endocrinology
• Gynecology

Background:

• Premature ovarian failure (POF) is defined by menstrual irregularities and elevated follicle-stimulating hormone (FSH) levels before age 40.
• The condition affects 1:1000 women under 30 and 1:100 under 40, often with unidentified causes.

Purpose of the Study:

• To outline the characteristics, incidence, and current management strategies for premature ovarian failure.
• To discuss fertility prospects and therapeutic interventions for POF patients.

Main Methods:

• Literature review of studies on premature ovarian failure.
• Analysis of diagnostic criteria including FSH levels and age of onset.
• Evaluation of fertility treatment success rates and hormone replacement therapy efficacy.

Main Results:

• Spontaneous conception rates after POF diagnosis are low (5-10%).
• No current treatments can restore ovarian function or improve natural pregnancy rates.
• In vitro fertilization with oocyte donation is the sole effective fertility treatment.
• Hormone replacement therapy can manage climacteric symptoms, but is not always necessary.

Conclusions:

• POF presents significant reproductive challenges with limited treatment options for ovarian restoration.
• Oocyte donation offers the only viable path to pregnancy for affected women.
• Future advancements like ovarian tissue cryopreservation may provide hope for at-risk individuals.